• Courtesy of Sarah G. Bonaffini DO; Akash Patel; Lin Yang; Joseph Mastellone; Stephen A. Ashe MD; Jared Matthews MD. Submitted by Andrew Fernandez, MD.
    File Size: 39 KB
    Cornea/External Disease

    The first case of new onset, multifocal epithelial defects as a direct consequence of cetuximab (Erbitux) therapy. This 76-year-old man received cetuximab for squamous cell cancer of the neck and developed multiple distinct bilateral epithelial defects due to EGFR inhibition.